Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 14.3% during the second quarter, according to its most recent filing with the SEC. The firm owned 53,046 shares of the medical instruments supplier’s stock after buying an additional 6,619 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in DENTSPLY SIRONA were worth $3,440,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in XRAY. Vanguard Group Inc. boosted its stake in DENTSPLY SIRONA by 2.7% in the first quarter. Vanguard Group Inc. now owns 22,165,069 shares of the medical instruments supplier’s stock worth $1,383,988,000 after buying an additional 584,536 shares during the last quarter. BlackRock Inc. boosted its stake in DENTSPLY SIRONA by 3,103.7% in the first quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock worth $867,376,000 after buying an additional 13,457,730 shares during the last quarter. State Street Corp boosted its stake in DENTSPLY SIRONA by 0.4% in the first quarter. State Street Corp now owns 9,931,689 shares of the medical instruments supplier’s stock worth $620,136,000 after buying an additional 36,012 shares during the last quarter. Veritas Asset Management LLP boosted its stake in DENTSPLY SIRONA by 5.0% in the first quarter. Veritas Asset Management LLP now owns 6,043,539 shares of the medical instruments supplier’s stock worth $377,359,000 after buying an additional 287,800 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its stake in DENTSPLY SIRONA by 1,445.2% in the first quarter. Principal Financial Group Inc. now owns 5,292,885 shares of the medical instruments supplier’s stock worth $330,488,000 after buying an additional 4,950,337 shares during the last quarter. Institutional investors own 93.97% of the company’s stock.

Shares of DENTSPLY SIRONA Inc. (XRAY) opened at 55.70 on Wednesday. The stock’s 50 day moving average is $59.93 and its 200-day moving average is $62.08. DENTSPLY SIRONA Inc. has a 52 week low of $52.53 and a 52 week high of $65.68. The stock’s market capitalization is $12.78 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The company had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. During the same quarter in the prior year, the business earned $0.76 earnings per share. The company’s revenue was down 2.9% compared to the same quarter last year. On average, analysts anticipate that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be given a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 0.63%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s payout ratio is -10.09%.

COPYRIGHT VIOLATION WARNING: “DENTSPLY SIRONA Inc. (XRAY) Stake Increased by Fjarde AP Fonden Fourth Swedish National Pension Fund” was first reported by Watch List News and is the property of of Watch List News. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The correct version of this news story can be accessed at https://www.watchlistnews.com/dentsply-sirona-inc-xray-stake-increased-by-fjarde-ap-fonden-fourth-swedish-national-pension-fund/1531765.html.

XRAY has been the topic of a number of recent analyst reports. UBS AG restated a “neutral” rating and set a $59.00 target price (down previously from $62.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. BidaskClub cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Jefferies Group LLC reduced their price objective on shares of DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating on the stock in a research report on Wednesday, August 23rd. Stifel Nicolaus reiterated a “buy” rating and set a $66.00 price objective (down previously from $70.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. Finally, Zacks Investment Research cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Monday, August 14th. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the company. The company has an average rating of “Hold” and an average price target of $66.08.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.